Wintac receives Termination Letter from Par Formulations

01 Mar 2019 Evaluate

Wintac has received a Termination Letter from Par Formulations notifying the termination of Business Transfer Agreement for non-fulfillment by Par Formulations and Wintac of certain conditions within the stipulated time limits, while reserving all of Buyer's rights, powers, privileges, remedies and defenses.

Earlier, the company had entered into a Business Transfer Agreement with Par Formulations on April 26, 2018 for the sale of Pharmaceutical Business Undertaking of the Company.

Wintac is a professionally managed and fully integrated pharmaceutical company that is committed in developing, manufacturing and marketing of high quality pharmaceutical formulations using innovative technologies and meeting the cGMP standards which are continuously updated to international requirements.

Wintac Share Price

341.60 0.00 (0.00%)
17-Dec-2020 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×